资源描述:
《保心安胶囊联合美托洛尔片治疗室性早搏临床观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、保心安胶囊联合美托洛尔片治疗室性早搏临床观察(河北邯郸明仁医院河北邯郸056006)【摘要】目的:研究保心安胶囊联合美托洛尔治疗室性早搏临床疗效。方法:采用随机数字表法,将200例室性早搏患者随机分为两组,治疗组100例在休息、吸氧、祛除病因基础上使用保心安胶囊和美托洛尔片联合治疗;对照组100例,给予在休息、吸氧、祛除病因基础上单纯使用美托洛尔片治疗,两组不同方案同时治疗4周,观察患者疗效及不良反应情况。结果:两组患者显效率无明显差异,但治疗组症状疗效总有效率为89%、动态心电图好转率88%,对照组症状疗效总有效率为48%、动态心电图好转率60
2、%,两组差异有统计学意义(P<0.05)而且治疗组治愈率明显高于对照组,两组差异有统计学意义(P<0.05),治疗组疗效优于对照组。结论:保心安胶囊联合美托洛尔片治疗室性早搏疗效肯定。【关键词】保心安胶囊:室性早搏;心律失常【中图分类号】R453【文献标识码】A【文章编号】1007-8231(2016)22-0010-03ClinicalobservationofcapsulecombinedwithmetoprololtabletsPosumonprematuretherapeuticroomYangXianghong,SongYu
3、qin,LiYuming,ZhangLihua,ZhangTiantao,HouBaosong,LiuXia.HandanMingrenHospital,Hebei,Handan,Hebei,056006【Abstract】ObjectiveTostudytheclinicaleffectofcapsulecombinedwithmetoprololinthetherapeuticroomprematurepeoplepeaceofmind.MethodsAccordingtotherandomnumbertablemethod,200patie
4、ntswithventricularprematurebeatwererandomlydividedinto2groups,100casesinthetreatmentgroupduringrest,oxygeninhalation,etiologicalfactorsbasedontheuseofcapsuleandmetoprololtabletscombinedwithPosumontreatment;100casesincontrolgroupweregivenintherest,oxygeninhalation,getridofthed
5、iseaseonthebasisof'simpleuseofmetoprololtreatmentatthesametime,twodifferentschemesfor4weeks.Theclinicalefficacyandadversereactionswereobserved.ResultsTheeffectiverateoftwogroupsofpatientshadnoobviousdifference,butthesymptomsinthetreatmentgroupthetotaleffectiveratewas89%,elect
6、rocardiogramimprovementratewas88%,controlgrouptotaleffectiverateofsymptomswas48%,electrocardiogramimprovementratewas60%,therewassignificantdifferencebetweentwogroups(P<0.05)andthetreatmentgroupcureratewassignificantlyhigherthanthecontrolgroup.Therewassignificantdifferenceb
7、etweentwogroups(P<0.05),thetreatmentgroupthanthecontrolgroup.ConclusionThecapsulecombinedwithmetoprololtabletsPosumonprematureclinicaltherapeuticroom.【Keywords]Posumoncapsule;Ventriculararrhythmia心律失常临床上十分常见iL可引起严重后果,发生于器质性心脏病的心律失常严重影响生活质量,甚则引起猝死。0前在治疗心律失常的用药上我们出现了“双难”窘境:治
8、疗室性早搏用药疗效欠佳,阵发性房颤缺乏长期冇效药物,对于缓慢性心律失常只能以肾上腺素、?受体兴奋剂、抗胆碱能药物等对症处理为主,但这些药